天立教育(01773.HK)停牌 將延遲發布2021年度業績
天立教育(01773.HK)公布,由於《中華人民共和國民辦教育促進法實施條例》於9月1日生效,仍在與核數師就實施條例可能對截至2021年8月31日止八個月的末期業績造成相關的會計處理的影響進行討論,目前尚未達成一致意見,因此無法根據上市規則發布業績。
公司表示,將盡最大努力在可行情況下盡快發布業績,將適時另行刊發公告,董事會會議亦將押後至另一日期舉行。
公司早前宣布,決議將財政年度結算日由12月31日更改為8月31日,因此2021年度業績將涵蓋2021年1月1日至8月31日的八個月期間表現。
應公司要求,股份自今早起短暫停牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.